Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Close this folder13. Partnership and collaboration
View the document13.1 The importance of supportive partners
View the document13.2 Possibilities at national, regional and international levels
Close this folder13.3 Various forms of collaboration
View the document13.3.1 Twinning arrangements
View the document13.3.2 Sharing information and resources
View the document13.3.3 Using established bulletins’ expertise
View the document13.3.4 Training sessions and workshops
View the document13.3.5 Ongoing information exchange between bulletins
View the document13.3.6 Collaborative research among bulletins
View the document13.3.7 Information and support for funding applications
View the document13.4 Identifying partners and networks
View the document13.5 Clearly define conditions for partnership
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information

13.3.2 Sharing information and resources

One of the biggest problems that new and small bulletins face is obtaining necessary information and reference materials, which are often too expensive for them to afford. If a bulletin can share resources and references with other drug bulletins or organizations, this can alleviate many of their difficulties in becoming established.

Lack of professional capacity and the scarcity of necessary materials invariably do not allow new bulletins to prepare all the in-depth review articles or original articles that they would like to produce. It helps them if they can use materials published by other drug bulletins, having first reached an agreement about this. (See Chapter 7 for more on sharing resources, and Chapter 11 on copyright.)

Exchange of documents that are difficult to obtain (for example, in the field of pharmacovigilance) among drug bulletins is always useful. Small and new or more experienced bulletins all face the same problems of lack of transparency, and difficult access to some data.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017